Company: ACBM
Filing Date: 2025-07-23
Form Type: 10-Q
Source: 0001640334-25-001281
Chunk: 2

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-23
Form: 10-Q
Item: Item 1
Chunk 2
---
Amount    Capital    Deficit   Deficit                       Balance, December 31, 2023  -  $-   60,042,000  $60,042  $32,298,442  $(32,615,498) $(257,014)                             Imputed interest on related party loans  -   -   -   -   954   -   954 Net loss  -   -   -   -   -   (11,252)  (11,252)                             Balance, March 31, 2024  -   -   60,042,000   60,042   32,299,396   (32,626,750)  (267,312)                             Imputed interest on related party loans  -   -   -   -   1,057   -   1,057 Net loss  -   -   -   -       (10,143)  (10,143)                             Balance, June 30, 2024  -   -   60,042,000   60,042   32,300,453   (32,636,893)  (276,398)                             Imputed interest on related party loans  -   -   -   -   1,123   -   1,123 Net loss  -   -   -   -       (10,229)  (10,229)                             Balance, September 30, 2024  -  $-   60,042,000  $60,042  $32,301,576  $(32,647,122) $(285,504)

For the Three and Nine months ended September 30, 2023

              Additional  Deferred       Total   Preferred Stock  Common Stock   Paid in   Stock  Accumulated  Stockholders'     Shares    Amount    Shares    Amount    Capital   Comp